Our experiments demonstrated that rhCCL15 treatment increased the phosphorylation of AKT (p-AKT) and ERK1/2 (p-ERK) in ESCC cells (Figure 6A-6B). The gene discussed is MAPK3; the disease is esophageal squamous cell carcinoma.